Springtime Surge: 43 Healthcare M&A Deals Signal Busy Season Ahead
The healthcare market has shown a significant increase in M&A activity since the start of April, with a total of 43 new deals recorded as of April 5th. The number of deals announced during the same period last year was lower at 38. So far, the announced deals point to a notable trend towards eHealth, with nine deals announced so far this month, making up approximately 21% of deals. By comparison, there were eight eHealth deals announced during the same period last year. Additionally, there has been an increase in Physician Medical Group deals, with 8 deals announced this year, compared to seven from last year. The specialties involved in these deals have also evolved, with a focus on... Read More »
Healthcare M&A Activity Will Post Another Drop in the First Quarter
With the first quarter of 2023 winding down, it is clear that healthcare M&A deal volume will continue to shrink. According to data captured in the LevinPro HC database on March 30, there were 502 deals recorded since the start of the year. This compares with 553 transactions posted in the fourth quarter of 2022, representing a 9% decline. This compares with totals of 612 and 598 in the third and second quarters of 2022, respectively. The current 2023 amount represents a 22% drop from the 647 posted in the first quarter of 2022. The eHealth sector has shown dramatic declines in deal volume from the 120 recorded in the first quarter of 2022. Transactions plummeted to 48 in the fourth... Read More »
Bad Timing: Fed Raises Borrowing Costs During ACG NY Healthcare Conference
Some of the leading experts in the healthcare industry convened at the ACG NY 15th Annual Healthcare Conference in New York City, and spirits were high amid the volatile environment surrounding M&A. No one brushed aside the headwinds facing the industry, such as inflation, labor shortages and costs, and rising interest rates during the March 22 event. Investors, analysts, lenders and advisors were confident they could close deals and grow businesses, but it’s going to require a more hands-on approach. “You need to have a tailored thesis for each business,” said Andrew Colbert, senior managing director at Ziegler, during one of the panel discussions. “You can’t have a... Read More »
The Transcripts: Takeaways from CVS, Teladoc, and DaVita Earnings
In our first earnings roundup, we looked at the fourth-quarter and full-year 2022 financial performance of three major publicly traded companies in the managed care market. They achieved positive operating and financial results for 2022, with some even surpassing their expectations for the year. To read more about earnings results in the managed care market, you can read that spotlight on the LevinPro HC platform here. This week, we’re looking at companies in other healthcare verticals, including retail, dialysis and eHealth. CVS Health Corporation, Teladoc Health, Inc. and DaVita Inc are all prominent in their respective fields, and their financial performance can reveal much about the... Read More »
The Managed Care Earnings Round-Up
Some of the largest Managed Care providers in the world have announced their earnings for 2022, and the results are looking promising for the Managed Care space. Humana Inc., Centene Corporation and Cigna Corp. all achieved positive operating and financial results for 2022, with some even surpassing their expectations for the year. However, M&A within the Managed Care sector slowed in 2022, with just 43 transactions announced, a 10.4% decrease from 2021 when 48 deals were announced. This decline is the result of a shift in these company’s growth strategy as they focus on cleaning up their portfolios through divestments. Humana Inc. (NYSE:HUM) Humana reported strong operating and... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
